[Results of radiation treatment of cervical cancer patients using the AGAT-V apparatus].
1,863 patients with cancer of cervix uteri received a complex radiation treatment from the ATAT-B installation in 1974-1982. Five-year survival of patients given different focal doses of 45-73 Gy (90-178 units TDF) was studied. It was found that approximately the same survival of patients treated with different focal doses within the said dose range was matched by minimal incidence and degree of radiation injuries following exposure to doses of 45-59 Gy (105-139 units TDF). Total focal dosage and TDF values, incidence rate and degree of post-radiation complications were shown to be in a direct correlation.
D000230:Adenocarcinoma / Q000150:complications / Q000401:mortality / Q000532:radiotherapy*; D000328:Adult; D000368:Aged; D001918:Brachytherapy / Q000009:adverse effects / Q000295:instrumentation*; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000401:mortality / Q000532:radiotherapy*; D003037:Cobalt Radioisotopes / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008875:Middle Aged; D011832:Radiation Injuries / Q000453:epidemiology; D011879:Radiotherapy Dosage; D002583:Uterine Cervical Neoplasms / Q000150:complications / Q000401:mortality / Q000532:radiotherapy*
D003037:Cobalt Radioisotopes
Rezul'taty luchevogo lecheniia bol'nykh rakom sheĭki matki s ispol'zovaniem apparata AGAT-V.